Sinigrin attenuates angiotensin II‑induced kidney injury by inactivating nuclear factor‑κB and extracellular signal‑regulated kinase signaling <em>in vivo</em> and <em>in vitro</em>

Cong,Cong; Yuan,Xiaohong; Hu,Ying; Chen,Wenjing; Wang,Yong; Tao,Lei

doi:10.3892/ijmm.2021.4994

Sinigrin attenuates angiotensin II‑induced kidney injury by inactivating nuclear factor‑κB and extracellular signal‑regulated kinase signaling in vivo and in vitro

Authors:
- Cong Cong
- Xiaohong Yuan
- Ying Hu
- Wenjing Chen
- Yong Wang
- Lei Tao
View Affiliations

Affiliations: Department of Cardiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China, Department of Traumatic Orthopaedics, The Third Affiliated Hospital of Shandong First Medical University (Affiliated Hospital of Shandong Academy of Medical Sciences), Jinan, Shandong 250031, P.R. China, Department of Science and Technology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China, Department of Nephrology, The Third Affiliated Hospital of Shandong First Medical University (Affiliated Hospital of Shandong Academy of Medical Sciences), Jinan, Shandong 250031, P.R. China
Published online on: July 2, 2021 https://doi.org/10.3892/ijmm.2021.4994
Article Number: 161
Copyright: © Cong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the function of sinigrin in angiotensin II (Ang II)‑induced renal damage. The results demonstrated that systolic blood pressure (SBP) and diastolic blood pressure (DBP) were increased in Ang II‑challenged rats, and sinigrin treatment inhibited their increase. The levels of blood urea nitrogen (BUN) and serum creatinine (SCR) were increased by Ang II in the rats, and these were reversed by sinigrin in a dose‑dependent manner. In addition, the Ang II‑induced elevation of urinary protein levels was inhibited by sinigrin treatment. Glomerular basement membrane thickness and ECM degradation markers, such as collagen I, collagen IV and fibronectin, were suppressed by sinigrin in the Ang II‑challenged rats. Moreover, the levels of inflammatory regulators, including tumor necrosis factor‑α (TNF‑α), interleukin‑6 (IL‑6) and monocyte chemoattractant protein‑1 (MCP‑1), were reduced following sinigrin treatment of the Ang II‑challenged rats and in Ang II‑exposed proximal tubule epithelial cells. Furthermore, the superoxide dismutase (SOD) and catalase (CAT) levels were downregulated, whereas the malondialdehyde (MDA) levels were upregulated by Ang II; these effects were reversed by sinigrin treatment in vivo and in vitro. Mechanistically, sinigrin inhibited the Ang II‑induced phosphorylation of ERK, p65 and IκBα. Thus, sinigrin attenuated Ang II‑induced renal injury by inactivating ERK and NF‑κB signaling. Sinigrin may thus prove to be a potential candidate for the treatment of hypertension‑induced kidney damage.

View Figures

View References

1	Manosroi W and Williams GH: Genetics of human primary hypertension: Focus on hormonal mechanisms. Endocr Rev. 40:825–856. 2019. View Article : Google Scholar
2	Suneja M and Sanders ML: Hypertensive emergency. Med Clin North Am. 101:465–478. 2017. View Article : Google Scholar : PubMed/NCBI
3	Xiong D, Hu W, Ye ST and Tan YS: Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways. Biochem Biophys Res Commun. 506:161–168. 2018. View Article : Google Scholar : PubMed/NCBI
4	Escobales N, Nuñez RE and Javadov S: Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Physiol Heart Circ Physiol. 316:H1426–H1438. 2019. View Article : Google Scholar : PubMed/NCBI
5	Li XC, Zhang J and Zhuo JL: The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res. 125:21–38. 2017. View Article : Google Scholar : PubMed/NCBI
6	Weber GJ, Pushpakumar SB and Sen U: Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism. Am J Physiol Heart Circ Physiol. 312:H874–H885. 2017. View Article : Google Scholar : PubMed/NCBI
7	Aroor AR, McKarns S, Demarco VG, Jia G and Sowers JR: Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism. 62:1543–1552. 2013. View Article : Google Scholar : PubMed/NCBI
8	Park JK, Müller DN, Mervaala EM, Dechend R, Fiebeler A, Schmidt F, Bieringer M, Schäfer O, Lindschau C, Schneider W, et al: Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int. 58:1420–1430. 2000. View Article : Google Scholar : PubMed/NCBI
9	Henke N, Schmidt-Ullrich R, Dechend R, Park JK, Qadri F, Wellner M, Obst M, Gross V, Dietz R, Luft FC, et al: Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circ Res. 101:268–276. 2007. View Article : Google Scholar : PubMed/NCBI
10	Zhang L, He S, Wang Y, Zhu X, Shao W, Xu Q and Cui Z: miRNA-20a suppressed lipopolysaccharide-induced HK-2 cells injury via NFκB and ERK1/2 signaling by targeting CXCL12. Mol Immunol. 118:117–123. 2020. View Article : Google Scholar
11	Wu SJ, Shi ZW, Wang X, Ren FF, Xie ZY, Lei L and Chen P: Activation of the cholinergic anti-inflammatory pathway attenuated angiotension II-dependent hypertension and renal injury. Front Pharmacol. 12:5936822021. View Article : Google Scholar : PubMed/NCBI
12	Wang L, Liu N, Xue X and Zhou S: The effect of overexpression of the enhancer of zeste homolog 1 (EZH1) gene on aristolochic acid-induced injury in HK-2 human kidney proximal tubule cells in vitro. Med Sci Monit. 25:801–810. 2019. View Article : Google Scholar : PubMed/NCBI
13	Lee HW, Rhee DK, Kim BO and Pyo S: Inhibitory effect of sinigrin on adipocyte differentiation in 3T3-L1 cells: Involvement of AMPK and MAPK pathways. Biomed Pharmacother. 102:670–680. 2018. View Article : Google Scholar : PubMed/NCBI
14	Jang YJ, Park B, Lee HW, Park HJ, Koo HJ, Kim BO, Sohn EH, Um SH and Pyo S: Sinigrin attenuates the progression of atherosclerosis in ApoE^−/− mice fed a high-cholesterol diet potentially by inhibiting VCAM-1 expression. Chem Biol Interact. 272:28–36. 2017. View Article : Google Scholar : PubMed/NCBI
15	Lee HW, Lee CG, Rhee DK, Um SH and Pyo S: Sinigrin inhibits production of inf lammatory mediators by suppressing NF-κB/MAPK pathways or NLRP3 inflammasome activation in macrophages. Int Immunopharmacol. 45:163–173. 2017. View Article : Google Scholar : PubMed/NCBI
16	Huang LL, Pan C, Yu TT, Guo K, Wang XH, Zhang JY, Wang HZ and Gao S: Benefical therapeutic effect of Chinese Herbal Xinji'erkang formula on hypertension-induced renal injury in the 2-kidney-1-clip hypertensive rats. Afr J Tradit Complement Altern Med. 11:16–27. 2014. View Article : Google Scholar : PubMed/NCBI
17	Zhou S, Guo J, Zhao L, Liao Y, Zhou Q, Cui Y, Hu W, Chen J, Ren X, Wei Q, et al: ADAMTS13 inhibits oxidative stress and ameliorates progressive chronic kidney disease following ischaemia/reperfusion injury. Acta Physiol (Oxf). 231:e135862021. View Article : Google Scholar
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
19	Nair AR, Ebenezer PJ, Saini Y and Francis J: Angiotensin II-induced hypertensive renal inflammation is mediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells. Exp Cell Res. 335:238–247. 2015. View Article : Google Scholar : PubMed/NCBI
20	Chen D, Xiong XQ, Zang YH, Tong Y, Zhou B, Chen Q, Li YH, Gao XY, Kang YM and Zhu GQ: BCL6 attenuates renal inflammation via negative regulation of NLRP3 transcription. Cell Death Dis. 8:e31562017. View Article : Google Scholar : PubMed/NCBI
21	Li X, Cai W, Xi W, Sun W, Shen W, Wei T, Chen X, Sun L, Zhou H, Sun Y, et al: MicroRNA-31 regulates immunosuppression in Ang II (Angiotensin II)-induced hypertension by targeting Ppp6C (protein phosphatase 6c). Hypertension. 73:e14–e24. 2019. View Article : Google Scholar : PubMed/NCBI
22	Awasthi S and Saraswathi NT: Sinigrin, a major glucosinolate from cruciferous vegetables restrains non-enzymatic glycation of albumin. Int J Biol Macromol. 83:410–415. 2016. View Article : Google Scholar
23	Teles F, da Silva TM, da Cruz Júnior FP, Honorato VH, de Oliveira Costa H, Barbosa AP, de Oliveira SG, Porfírio Z, Libório AB, Borges RL and Fanelli C: Brazilian red propolis attenuates hypertension and renal damage in 5/6 renal ablation model. PLoS One. 10:e01165352015. View Article : Google Scholar : PubMed/NCBI
24	Gómez GI and Velarde V: Boldine improves kidney damage in the goldblatt 2K1C model avoiding the increase in TGF-β. Int J Mol Sci. 19:18642018. View Article : Google Scholar
25	Subedi L, Venkatesan R and Kim SY: Neuroprotective and anti-inflammatory activities of Allyl isothiocyanate through attenuation of JNK/NF-κB/TNF-α signaling. Int J Mol Sci. 18:14232017. View Article : Google Scholar
26	Mays JR, Weller Roska RL, Sarfaraz S, Mukhtar H and Rajski SR: Identification, synthesis, and enzymology of non-natural glucosinolate chemopreventive candidates. Chembiochem. 9:729–747. 2008. View Article : Google Scholar : PubMed/NCBI
27	Smith TK, Mithen R and Johnson IT: Effects of Brassica vegetable juice on the induction of apoptosis and aberrant crypt foci in rat colonic mucosal crypts in vivo. Carcinogenesis. 24:491–495. 2003. View Article : Google Scholar : PubMed/NCBI
28	Oyagbemi AA, Omobowale TO, Ola-Davies OE, Asenuga ER, Ajibade TO, Adejumobi OA, Arojojoye OA, Afolabi JM, Ogunpolu BS, Falayi OO, et al: Quercetin attenuates hypertension induced by sodium fluoride via reduction in oxidative stress and modulation of HSP 70/ERK/PPARγ signaling pathways. Biofactors. 44:465–479. 2018. View Article : Google Scholar : PubMed/NCBI
29	Chen LJ, Xu YL, Song B, Yu HM, Oudit GY, Xu R, Zhang ZZ, Jin HY, Chang Q, Zhu DL and Zhong JC: Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice. Peptides. 79:49–57. 2016. View Article : Google Scholar : PubMed/NCBI
30	Ceron CS, Rizzi E, Guimaraes DA, Martins-Oliveira A, Gerlach RF and Tanus-Santos JE: Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension. Free Radic Biol Med. 65:47–56. 2013. View Article : Google Scholar : PubMed/NCBI
31	Qi J, Yu XJ, Fu LY, Liu KL, Gao TT, Tu JW, Kang KB, Shi XL, Li HB, Li Y and Kang YM: Exercise training attenuates hypertension through TLR4/MyD88/NF-κB signaling in the hypothalamic paraventricular nucleus. Front Neurosci. 13:11382019. View Article : Google Scholar
32	Oyagbemi AA, Omobowale TO, Ola-Davies OE, Asenuga ER, Ajibade TO, Adejumobi OA, Afolabi JM, Ogunpolu BS, Falayi OO, Ayodeji F, et al: Ameliorative effect of Rutin on sodium fluoride-induced hypertension through modulation of Kim-1/NF-κB/Nrf2 signaling pathway in rats. Environ Toxicol. 33:1284–1297. 2018. View Article : Google Scholar : PubMed/NCBI